Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Pulmatrix Inc PULM

Healthcare Biotechnology
Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic... see more

Current News (NDAQ:PULM)

Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets

PR Newswire October 16, 2025

Pulmatrix Announces Second Quarter 2025 Financial Results and Divestment Plan for Inhalation Assets

PR Newswire August 6, 2025

Pulmatrix Announces First Quarter 2025 Financial Results and Divestment Plan for Assets

PR Newswire May 15, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RDUS, COOP, ICAD, PULM on Behalf of Shareholders

PR Newswire May 13, 2025

PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc. - PULM

Business Wire May 9, 2025

Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets

PR Newswire March 21, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TGI, PULM, CCNE, TURN on Behalf of Shareholders

PR Newswire February 25, 2025

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Pulmatrix, Inc. (PULM)

Newsfile February 24, 2025

PULM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pulmatrix, Inc. Is Fair to Shareholders

Business Wire February 19, 2025
View More News ››

Opinion & Analysis (NDAQ:PULM)

Pulmatrix's Licensing Deal with the JNJ Lung Cancer Initiative Sends Shares Up 100%

Streetwise Reports January 3, 2020
View More Opinion ››

Bullboard Posts (NDAQ:PULM)

Pulmatrix, Inc. (PULM): Inhaled Therapeutics Specialist Navi

http://beyondspx.com/2024/08/02/pulmatrix-inc-pulm-inhaled-therapeutics-specialist-navigating-challenges-seeking-partnerships-to-advance...
MikeTester - August 3, 2024

it's a buy today for me

it looks like its time has come to perform,off my watchlist,so glta shareholders.
coolfooldumbguy - January 2, 2020

watching this one for

an entry point,but not yet,so glta.
coolfooldumbguy - April 4, 2019

RE:RE:Wainwright Report $5 Target

However the incompetent finance team issues yet another awful financing. Only an idiot would issue more warrants st this stage. Total...
dmacd - April 4, 2019

RE:Wainwright Report $5 Target

A nice day for sure and validates what a few of us have known for some time now that the company was ridiculously undervalued. The deal...
dmacd - April 1, 2019

Wainwright Report $5 Target

Discounted success by 10 factor so max upside is $50/sh based on assumptions. Indicates $15M/a spend till 2023 but didn't factor in...
dmacd - March 12, 2019
View more Bullboard ››

Eshbal Functional Food Inc

Eshbal Functional Food Inc

Eshbal Functional Food Inc. researches, develops, and manufactures food products and dietary supplements Israel, North ...
View More »

Podcasts